Complexities of adherence and post-cancer lymphedema management

Journal of Personalized Medicine

Volumn 5, Issue 4, 2015, Pages 370-388

  Ostby, Pamela L ^a   Armer, Jane M ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Adherence; Breast cancer; Compliance; Lymphedema; Management; Self care; Symptom distress; Treatment burden

Indexed keywords

ANXIETY; ARTICLE; BREAST CANCER; BREAST CANCER RELATED LYMPHEDEMA; CANCER SURVIVOR; COMORBIDITY; DEPRESSION; DISTRESS SYNDROME; EMOTIONAL DISORDER; HEALTH CARE PERSONNEL; HUMAN; LYMPHEDEMA; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF CARE; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW (TOPIC);

EID: 84983638718     PISSN: None     EISSN: 20754426     Source Type: Journal    
DOI: 10.3390/jpm5040370     Document Type: Article

References (66)

1. Cancer Treatment & Survivorship Facts & Figures 2014-2015. 2015. Available online: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-042801.pdf (accessed on 15 October 2015).
2. Armer, J.M.; Henggeler, M.H.; Brooks, C.W.; Zagar, E.A.; Homan, S.; Stewart, B.R. The health deviation of post-breast cancer lymphedema: Symptom assessment and impact on self-care agency. Self Care Depend. Care Nurs. 2008, 16, 14-21.
3. Khan, S. Axillary reverse mapping to prevent lymphedema after breast cancer surgery: Defining the limits of the concept. J. Clin. Oncol. 2009, 27, 5494-5496.
4. Armer, J.M.; Radina, M.E.; Porock, D.; Culbertson, S.D. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs. Res. 2003, 52, 370-379.
5. Fu, M.R.; Chen, C.M.; Haber, J.; Guth, A.A.; Axelrod, D. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors. Ann. Surg. Oncol. 2010, 17, 1847-1853.
6. Ridner, S.H.; Fu, M.R.; Wanchai, A.; Stewart, B.R.; Armer, J.M.; Cormier, J.N. Self-management of lymphedema: A systematic review of the literature from 2004 to 2011. Nurs. Res. 2012, 61, 291-299.
7. Lasinski, B.B.; McKillip Thrift, K.; Squire, D.; Austin, M.K.; Smith, K.M.; Wanchai, A.; Green, J.M.; Stewart, B.R.; Cormier, J.N.; Armer, J.M. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. Am. J. Phys. Med. Rehab. 2012, 4, 580-601.
8. Armer, J.M.; Brooks, C.W.; Stewart, B.R. Limitations of self-care in reducing the risk of lymphedema: Supportive-educative systems. Nurs. Sci. Quart. 2011, 24, 57-63.
9. Brown, J.C.; Cheville, A.L.; Tchou, J.C.; Harris, S.R.; Schmitz, K.H. Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema. Support Care Cancer 2014, 22, 135-143.
10. Haynes, R.; Sackett, D. Compliance with Therapeutic Regimens; Johns Hopkins University Press: Baltimore, MD, USA, 1976.
11. Lutfey, K.; Wishner, W. Beyond "compliance" is "adherence": Improving the prospect of diabetes care. Diabetes Care 1999, 22, 635-639.
12. Robinson, J.H.; Callister, L.C.; Berry, J.A.; Dearing, K.A. Patient-centered care and adherence: Definitions and applications to improve outcomes. J. Am. Acad. Nurse Pract. 2008, 20, 600-607.
13. Vermeire, E.; Hearnshaw, H.; van Royen, P.; Denekens, J. Patient adherence to treatment: Three decades of research. A comprehensive review. J. Clin. Pharm. Ther. 2001, 26, 331-342.
14. Armer, J.M.; Hulett, J.M.; Bernas, M.; Ostby, P.; Stewart, B.R.; Cormier, J.N. Best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. Curr. Breast Cancer Rep. 2013, 5, 134-144.
15. Fu, M.R.; Ridner, S.H.; Hu, S.H.; Stewart, B.R.; Cormier, J.N.; Armer, J.M. Psychosocial impact of lymphedema: A systematic review of literature from 2004 to 2011. Psychooncology 2013, 22, 1466-1484.
16. Fu, M.R.; Kang, Y. Psychosocial impact of living with cancer-related lymphedema. Semin. Oncol. Nurs. 2013, 29, 50-60.
17. Ridner, S.H.; Dietrich, M.S.; Kidd, N. Breast cancer treatment-related lymphedema self-care: Education, practices, symptoms, and quality of life. Support Care Cancer 2011, 19, 631-637.
18. Sherman, K.A.; Koelmeyer, L. Psychosocial predictors of adherence to lymphedema risk minimization guidelines among women with breast cancer. Psychooncology 2013, 22, 1120-1126.
19. Boris, M.; Lasinski, B. Lymphedema reduction by noninvasive complex lymphedema therapy. Oncology 1994, 8, 95-106.
20. Stout, N.L.; Pfalzer, L.A.; Springer, B.; Levy, E.; McGarvey, C.L.; Danoff, J.V.; Gerber, L.H.; Soballe, P.W. Breast cancer-related lymphedema: Comparing direct costs of a prospective surveillance model and a traditional model of care. Phys. Ther. 2012, 92, 152-163.
21. Norman, D. Living with Complexity; MIT Press: Cambridge, MA, USA, 2010.
22. Ridgeway, J.L.; Egginton, J.S.; Tiedje, K.; Linzer, M.; Boehm, D.; Poplau, S.; de Oliveira, D.R.; Odell, L.; Montori, V.M.; Eton, D.T. Factors that lessen the burden of treatment in complex patients with chronic conditions: A qualitative study. Patient Prefer Adher. 2014, 8, 339-351.
23. Fu, M.R.; Rosedale, M. Breast cancer survivors' experiences of lymphedema-related symptoms. J. Pain Symptom Manag. 2009, 38, 849-859.
24. National Comprehensive Cancer Network (NCCN). Distress management guidelines. 2015. Available online: http://www.nccn.org/professionals/physician_gls/pdf/distress.pdf (accessed on 14 September 2015).
25. Ridner, S.H.; Dietrich, M.S. Self-reported comorbid conditions and medication usage in breast cancer survivors with and without lymphedema. Oncol. Nurs. Forum 2008, 35, 57-63.
26. Rosedale, M.; Fu, M.R. Confronting the unexpected: Temporal, situational, and attributive dimensions of distressing symptom experience for breast cancer survivors. Oncol. Nurs. Forum 2010, 37, E28-E33.
27. Armer, J.M.; Shook, R.P.; Schneider, M.K.; Brooks, C.W.; Peterson, J.; Stewart, B.R. Enhancing Supportive-Educative Nursing Systems to Reduce Risk of Post-Breast Cancer Lymphedema. Self Care Depend. Care Nurs. 2009, 17, 6-15.
28. McWayne, J.; Heiney, S.P. Psychologic and social sequelae of secondary lymphedema. Cancer 2005, 104, 457-466.
29. Paskett, E.D.; Stark, N. Lymphedema: Knowledge, Treatment, and Impact Among Breast Cancer Survivors. Breast J. 2000, 6, 373-378.
30. Ridner, S.H. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer 2005, 13, 904-911.
31. Sherman, K.; Koelmeyer, L. The role of information sources and objective risk status on lymphedema risk-minimization behaviors in women recently diagnosed with breast cancer. Oncol. Nurs. Forum 2011, 38, E27-E36.
32. Tsuchiya, M.; Horn, S.; Ingham, R. Information provision and problem-solving processes in Japanese breast cancer survivors with lymphoedema symptoms. Scand. J. Caring Sci. 2012, 26, 53-60.
33. Leventhal, H.; Meyer, D.; Nerenz, D. The common sense representation of illness danger. In Contributions to Medical Psychology, 2nd ed.; Rachman, S., Ed.; Pergamon Press: New York, NY, USA, 1980; pp. 7-30.
34. Leventhal, H.; Safer, M.A.; Cleary, P.D.; Gutmann, M. Cardiovascular risk modification by community-based programs for life-style change: Comments on the Stanford study. J. Consult Clin. Psychol. 1980, 48, 150-158.
35. Lau, R.R.; Hartman, K.A. Common sense representations of common illnesses. Health Psychol. 1983, 2, 167-185.
36. Leventhal, H.; Leventhal, E.; Cameron, L. Representations, procedures, andeffect in illness self-regulation a perceptual cognitive model. In Handbook of Health Psychology; Baum, A., Revenson, T., Singer, J., Eds.; Lawrence Erlbaum Assoc Inc.: Mah-wah, NJ, USA, 2001; pp. 19-48.
37. Leventhal, H.; Leventhal, E.A.; Breland, J.Y. Cognitive Science Speaks to the "Common-Sense" of Chronic Illness Management. Ann. Behav. Med. 2011, 41, 152-163.
38. Sherman, K.A.; Miller, S.M.; Roussi, P.; Taylor, A. Factors predicting adherence to risk management behaviors of women at increased risk for developing lymphedema. Support Care Cancer 2015, 23, 61-69.
39. Deng, J.; Fu, M.R.; Armer, J.M.; Cormier, J.N.; Radina, E.; Thiadens, S.R.; Dietrich, M.S.; Weiss, J.; Tuppo, C.M.; Ridner, S.H. Self-reported information sources and perceived knowledge in individuals with lymphedema. Lymphology 2013, 46, 173-183.
40. Paskett, E.D.; Dean, J.A.; Oliveri, J.M.; Harrop, J.P. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: A review. J. Clin. Oncol. 2012, 30, 3726-3733.
41. Cormier, J.; Xing, Y.; Zaniletti, I.; Askew, R.; Stewart, B.; Armer, J. Minimal limb volume change has a significant impact on breast cancer survivors. Lympihology 2009, 42, 161-175.
42. Shippee, N.D.; Shah, N.D.; May, C.R.; Mair, F.S.; Montori, V.M. Cumulative complexity: A functional, patient-centered model of patient complexity can improve research and practice. J. Clin. Epidemiol. 2012, 65, 1041-1051.
43. Lasinski, B.B. Complete decongestive therapy for treatment of lymphedema. Semin. Oncol. Nurs. 2013, 29, 20-27.
44. National Lymphedema Network. The diagnosis and treatment of lymphedema. 2015. Available online: http://www.lymphnet.org/lymphedemaFAQs/positionPapers.htm (accessed on 19 August 2015).
45. Stout Gergich, N.L.; Pfalzer, L.A.; McGarvey, C.; Springer, B.; Gerber, L.H.; Soballe, P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 2008, 112, 2809-2819.
46. National Cancer Institute. Lymphedema PDQ. 2015. Available online: http://www.cancer.gov/ cancertopics/pdq/supportivecare/lymphedema/healthprofessional (accessed on July 9 2015).
47. Kaviani, A.; Fateh, M.; Yousefi Nooraie, R.; Alinagi-zadeh, M.R.; Ataie-Fashtami, L. Low-level laser therapy in management of postmastectomy lymphedema. Lasers Med. Sci. 2006, 21, 90-94.
48. Omar, M.; Shaheen, A.; Zafar, H. A systematic review of the effect of low-level laser therapy in the management of breast cancer-related lymphedema. Support Care Cancer 2012, 20, 2977-2984.
49. Heppner, P.; Tierney, C.; Armer, J.; Whitlow, N.; Reynolds, A. Breast cancer survivors coping with lymphedema: What all counselors need to know. J. Couns. Dev. 2009, 87, 327-338.
50. Armer, J.; Fu, M.R.; Wainstock, J.M.; Zagar, E.; Jacobs, L.K. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology 2004, 37, 73-91.
51. Dominick, S.A.; Natarajan, L.; Pierce, J.P.; Madanat, H.; Madlensky, L. The psychosocial impact of lymphedema-related distress among breast cancer survivors in the WHEL Study. Psychooncology 2014, 23, 1049-1056.
52. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology 2013, 46, 1-11.
53. Ostby, P.L.; Armer, J.M.; Dale, P.S.; van Loo, M.J.; Wilbanks, C.L.; Stewart, B.R. Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema. J. Pers. Med. 2014, 4, 424-447.
54. Armer, J.M.; Stewart, B.R. Post-breast cancer lymphedema: Incidence increases from 12 to 30 to 60 months. Lymphology 2010, 43, 118-127.
55. Hulett, J.; Armer, J.; Stewart, B.; Wanchai, A. Perspectives of the Breast Cancer Survivorship Continuum: Diagnosis through 30 Months Post-Treatment. J. Pers. Med. 2015, 5, 174-190.
56. Armer, J.M.; Whitman, M. The problem of lymphedema following breast cancer treatment: Prevalence, symptoms, & self-management. Lymphology 2002, 35, 153-159.
57. Ridner, S.H.; Deng, J.; Fu, M.R.; Radina, E.; Thiadens, S.R.; Weiss, J.; Dietrich, M.S.; Cormier, J.N.; Tuppo, C.M.; Armer, J.M. Symptom burden and infection occurrence among individuals with extremity lymphedema. Lymphology 2012, 45, 113-123.
58. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. 2015. Available online: http://seer.cancer.gov (accessed on 26 October 2015).
59. Nazarko, L. Understanding lymphoedema in older people. Nurs. Resid. Care 2006, 8, 254-258.
60. Armer, J.M.; Stewart, B.R.; Wanchai, A.; Lasinski, B.B.; Smith, K.M.; Cormier, J.N. Rehabilitation Concepts Among Aging Survivors Living With and At Risk for Lymphedema. Top. Geriat Rehabil. 2012, 28, 260-268.
61. Bellury, L.; Ellington, L.; Beck, S.L.; Pett, M.A.; Clark, J.; Stein, K. Older breast cancer survivors: Can interaction analyses identify vulnerable subgroups? A report from the American Cancer Society Studies of Cancer Survivors. Oncol. Nurs. Forum 2013, 40, 325-336.
62. Ridner, S.H.; Bonner, C.M.; Doersam, J.K.; Rhoten, B.A.; Schultze, B.; Dietrich, M.S. Bioelectrical impedance self-measurement protocol development and daily variation between healthy volunteers and breast cancer survivors with lymphedema. Lymphat. Res. Biol. 2014, 12, 2-9.
63. Forner-Cordero, I.; Muñoz-Langa, J.; Forner-Cordero, A.; DeMiguel-Jimeno, J. Predictive factors of response to decongestive therapy in patients with breast-cancer-related lymphedema. Ann. Surg. Oncol. 2010, 17, 744-751.
64. Tidhar, D.; Katz-Leurer, M. Aqua lymphatic therapy in women who suffer from breast cancer treatment-related lymphedema: A randomized controlled study. Support Care Cancer 2010, 18, 383-392.
65. Letellier, M.E.; Towers, A.; Shimony, A.; Tidhar, D. Breast cancer-related lymphedema: A randomized controlled pilot and feasibility study. Am. J. Phys. Med. Rehabil. 2014, 93, 751-759.
66. Olson, R.; Schmidt, S.; Winkler, C.; Wipfli, B. The effects of target behavior choice and self-management skills training on compliance with behavioral self-monitoring. Am. J. Health Promot. 2011, 25, 319-324.